(Q37973431)

26 August 2017

title

Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization (English)

1 reference

26 August 2017

1 reference

Neha Saraf

1

1 reference

26 August 2017

Promod K Sharma

2

1 reference

26 August 2017

Sambhu C Mondal

3

1 reference

26 August 2017

Vipin K Garg

4

1 reference

26 August 2017

Avnesh K Singh

5

1 reference

26 August 2017

publication date

13 October 2011

1 reference

Journal of Pharmacy and Pharmacology

26 August 2017

published in

1 reference

26 August 2017

volume

64

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

161-171

1 reference

Adipose tissue as an endocrine organ

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Inverse relation between FASN expression in human adipose tissue and the insulin resistance level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Adipose tissue as a regulator of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The many faces of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Sending the signal: molecular mechanisms regulating glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Identification of a novel gene encoding an insulin-responsive glucose transporter protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

21 January 2018

The PPAR resource page.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

PPARgamma, the ultimate thrifty gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Depot-specific effects of the PPARgamma agonist rosiglitazone on adipose tissue glucose uptake and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

A transcriptional co-repressor that interacts with nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Coactivator and corepressor complexes in nuclear receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Genetics of leptin and obesity: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Adipogenesis: forces that tip the scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Impact of genetic variation of PPARgamma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-γ activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Adipokines, inflammation, and the endothelium in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

PPARgamma promoter polymorphisms and acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

PPARgamma in human and mouse physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2011.01366.X

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1111/J.2042-7158.2011.01366.X

15 July 2023

Identifiers

DOI

1 reference

26 August 2017

1 reference